CORREGENE Trademark

Trademark Overview


On Thursday, February 17, 2022, a trademark application was filed for CORREGENE with the United States Patent and Trademark Office. The USPTO has given the CORREGENE trademark a serial number of 79339878. The federal status of this trademark filing is REGISTERED as of Tuesday, August 8, 2023. This trademark is owned by Corregene Biotechnology Co., Ltd. The CORREGENE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Cultures of microorganisms for medical or veterinary use; diagnostic preparations for medical purposes; chemical reagents for medical or veterinary purposes; enzyme preparations for medical purposes; stem cells for medical purposes; biological tissue cultures for medical purposes; surgical implants comprised of living tissues; biological preparations for medical purposes for the treatment of tumors, cancer, precancerous lesions, chronic infections, autoimmune diseases, fatty liver, inflammatory bowel disease, cervical neoplasia, viral infections, metabolic diseases, immunodeficiency, osteoarthritis, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, allergic, immune disorder, TORCH infections and immunoglobulin diseases; veterinary preparations for the prevention and treatment of intestinal bacteria, coli...

product quality testing of pharmaceuticals; technical research in the field of pharmaceutical studies; research and development of drugs; medical and scientific research, namely, conducting clinical trials for others; genomic structure and function analysis; genetic testing for scientific research; the testing of starting materials, intermediate products and end products of protein, cell and gene therapy pharmaceutical products
corregene

General Information


Serial Number79339878
Word MarkCORREGENE
Filing DateThursday, February 17, 2022
Status700 - REGISTERED
Status DateTuesday, August 8, 2023
Registration Number7129005
Registration DateTuesday, August 8, 2023
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, May 23, 2023

Trademark Statements


Goods and ServicesCultures of microorganisms for medical or veterinary use; diagnostic preparations for medical purposes; chemical reagents for medical or veterinary purposes; enzyme preparations for medical purposes; stem cells for medical purposes; biological tissue cultures for medical purposes; surgical implants comprised of living tissues; biological preparations for medical purposes for the treatment of tumors, cancer, precancerous lesions, chronic infections, autoimmune diseases, fatty liver, inflammatory bowel disease, cervical neoplasia, viral infections, metabolic diseases, immunodeficiency, osteoarthritis, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, allergic, immune disorder, TORCH infections and immunoglobulin diseases; veterinary preparations for the prevention and treatment of intestinal bacteria, colibacillosis, salmonellosis, pasteurella, brucellosis, foot-and-mouth disease, tuberculosis, plague, infectious diseases, influenza, immune related diseases and nutrient deficiency related diseases; stem cells for veterinary purposes; preparations for destroying noxious animals
Pseudo MarkCORRE GENE
Goods and Servicesproduct quality testing of pharmaceuticals; technical research in the field of pharmaceutical studies; research and development of drugs; medical and scientific research, namely, conducting clinical trials for others; genomic structure and function analysis; genetic testing for scientific research; the testing of starting materials, intermediate products and end products of protein, cell and gene therapy pharmaceutical products

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 6, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, May 6, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCorregene Biotechnology Co., Ltd
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCN

Party NameCorregene Biotechnology Co., Ltd
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCN

Party NameCorregene Biotechnology Co., Ltd
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCN

Trademark Events


Event DateEvent Description
Sunday, February 11, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, February 11, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Sunday, February 11, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sunday, February 11, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, December 3, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, November 9, 2023FINAL DISPOSITION NOTICE SENT TO IB
Thursday, November 9, 2023FINAL DISPOSITION PROCESSED
Wednesday, November 8, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, August 8, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 8, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, May 23, 2023NOTIFICATION PROCESSED BY IB
Tuesday, May 23, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 23, 2023PUBLISHED FOR OPPOSITION
Wednesday, May 3, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, May 3, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, May 3, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 19, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, April 15, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 14, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 14, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, March 25, 2023NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, November 15, 2022REFUSAL PROCESSED BY IB
Friday, October 21, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, October 21, 2022REFUSAL PROCESSED BY MPU
Wednesday, August 31, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, August 30, 2022NON-FINAL ACTION WRITTEN
Thursday, August 25, 2022ASSIGNED TO EXAMINER
Tuesday, May 10, 2022APPLICATION FILING RECEIPT MAILED
Friday, May 6, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 5, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB